|
WO2010017999A1
|
|
Process
|
|
EP2024506A1
|
|
Method for reducing impurity level in mycophenolic acid fermentation
|
|
EP2108013A2
|
|
Crystalline forms of deferasirox
|
|
CN101258156A
|
|
Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same
|
|
WO2006069386A1
|
|
Method of purifying tacrolimus
|
|
WO2006060614A1
|
|
Methods for preparing pimecrolimus
|
|
EP1768969A2
|
|
Crystalline mycophenolate sodium
|
|
EP1641438A1
|
|
Process for the preparation of the amorphous form of a drug
|
|
CN1906184A
|
|
Mycophenolate mofetil impurity
|
|
EP1675841A1
|
|
Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
|
|
CN1906186A
|
|
Process for preparation of mycophenolic acid and ester derivatives thereof
|
|
US7232486B2
|
|
Crystallization and purification of macrolides
|
|
CA2551203A1
|
|
Novel forms of pravastatin sodium
|
|
EP1798214A1
|
|
Process for recovering statin compounds from a fermentation broth
|
